Ran Duan

Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US

Magaly Perez‐Nieves, Samaneh Kabul, Urvi Desai et al. · Current Medical Research and Opinion · 2015 · 46 citations · Full text

Tumor Microenvironment Status Predicts the Efficacy of Postoperative Chemotherapy or Radiochemotherapy in Resected Gastric Cancer

Ran Duan, Xiaoqin Li, Dongqiang Zeng et al. · Frontiers in Immunology · 2021 · 26 citations · Full text

FOLFIRI (folinic acid, fluorouracil, and irinotecan) increases not efficacy but toxicity compared with single-agent irinotecan as a second-line treatment in metastatic colorectal cancer patients: a randomized clinical trial

Xiaowei Zhang, Ran Duan, Yusheng Wang et al. · Therapeutic Advances in Medical Oncology · 2022 · 26 citations · Full text

Patient-reported outcomes in transition from high-dose U-100 insulin to human regular U-500 insulin in severely insulin-resistant patients with type 2 diabetes: analysis of a randomized clinical trial

Samaneh Kabul, Robert C. Hood, Ran Duan et al. · Health and Quality of Life Outcomes · 2016 · 20 citations · Full text

Glycaemic outcomes of an <scp>I</scp> ndividualized treat <scp>M</scp> ent a <scp>P</scp> proach for old <scp>ER</scp> vulnerable pat <scp>I</scp> ents: <scp>A</scp> randomized, controlled st <scp>U</scp> dy in type 2 diabetes <scp>M</scp> ellitus ( <scp>IMPERIUM</scp> )

Simon Heller, Richard E. Pratley, Alan J. Sinclair et al. · Diabetes Obesity and Metabolism · 2017 · 20 citations · Full text